Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after hip or knee replacement: pooled analysis of the RE MOBILIZE, RE-MODEL and RE-NOVATE trials

Autoren

Friedmann R, Dahl O, Francis C, Kurth A, Liebermann JR, Rosencher N, Clemens A, Hantel S, Schnee J, Eriksson BI, Caprini JA, for the RE-MODEL, RE-NOVATE and RE-MOBILIZE Steering Committees

Abstract